CorMedix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.

About CRMD

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. 

CEO
Joseph Todisco
CEOJoseph Todisco
Employees
65
Employees65
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2006
Founded2006
Employees
65
Employees65

CRMD Key Statistics

Market cap
574.37M
Market cap574.37M
Price-Earnings ratio
3.62
Price-Earnings ratio3.62
Dividend yield
Dividend yield
Average volume
5.76M
Average volume5.76M
High today
$7.52
High today$7.52
Low today
$7.15
Low today$7.15
Open price
$7.36
Open price$7.36
Volume
2.52M
Volume2.52M
52 Week high
$17.43
52 Week high$17.43
52 Week low
$5.60
52 Week low$5.60

Stock Snapshot

CorMedix(CRMD) stock is priced at $7.28, giving the company a market capitalization of 574.37M. It carries a P/E multiple of 3.62.

On 2026-01-23, CorMedix(CRMD) stock moved within a range of $7.15 to $7.52. With shares now at $7.28, the stock is trading +1.9% above its intraday low and -3.2% below the session's peak.

Trading volume for CorMedix(CRMD) stock has reached 2.52M, versus its average volume of 5.76M.

The stock's 52-week range extends from a low of $5.60 to a high of $17.43.

The stock's 52-week range extends from a low of $5.60 to a high of $17.43.

CRMD News

TipRanks 17h
CorMedix price target lowered to $13 from $18 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on CorMedix (CRMD) to $13 from $18 and keeps a Buy rating on the shares. The firm says expectations have been re...

Simply Wall St 7d
CorMedix Is Down 11.1% After CEO Becomes Chair And Sets 2026 Revenue Target - Has The Bull Case Changed?

Earlier this month, CorMedix Inc. reshaped its leadership structure by naming CEO Joseph Todisco as Chairman of the Board, appointing Mike Seckler as EVP & Chie...

CorMedix Is Down 11.1% After CEO Becomes Chair And Sets 2026 Revenue Target - Has The Bull Case Changed?

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CRMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.